Several bacterial protein toxins require activation by eukaryotic proteases. Previous studies have shown that anthrax toxin protective antigen (PA), Pseudomonas exotoxin A (PE), and diphtheria toxin (DT) are cleaved by furin C-terminal to the sequences RKKR, RQPR, and RVRR, respectively. Because furin-deficient cells retain some sensitivity to PA and DT, it is evident that other cellular proteases can activate these toxins. Whereas furin has been shown to require arginine residues at positions ؊1 and ؊4 for substrate recognition, another protease with an activity which could substitute for furin in toxin activation, the furin-related protease PACE4, requires basic residues in the ؊1, ؊2, and ؊4 positions of the substrate sequence. To examine the relative roles of furin and PACE4 in toxin activation, we used furin-deficient CHO cells (FD11 cells) transfected with either the furin (FD11/furin cells) or PACE4 (FD11/PACE4 cells) gene. Mutant PA proteins containing the cleavage sequence RAAR or KR were cytotoxic toward cells expressing only PACE4. In vitro cleavage data demonstrated that PACE4 can recognize RAAR and, to a much lesser extent, KR and RR. When extracts from PACE4-transfected cells were used as a source of proteases, PACE4 had minimal activity, indicating that it had been partially inactivated or did not remain associated with the cell membranes. Cleavage of iodinated PA containing the sequence RKKR or RAAR was detected on the surface of all cell types tested, but cleavage of a dibasic sequence was detected only intracellularly and only in cells that expressed furin or PACE4. The data provide evidence that PACE4 is present at the exterior of cells, that it plays a role in the proteolytic activation of anthrax toxin PA, and that PACE4 can activate substrates at the sequence RAAR or KR.
Anthrax toxin protective antigen (PA), Pseudomonas exotoxin A (PE), and diphtheria toxin (DT) are bacterial protein toxins that must be proteolytically processed for activity toward mammalian cells (9) . The salient structural difference between the three toxins is that whereas PE and DT each consists of a single polypeptide with domains responsible for cell-binding, translocation, and enzymatic activities, anthrax toxin is a binary toxin which requires, besides PA, a second protein that has an enzymatic activity. PA, PE, and DT interact with target cells differently. PA binds to a cell surface receptor, after which cleavage takes place, releasing a 20-kDa polypeptide into the culture supernatant. This exposes a binding site for lethal factor (LF) on the 63-kDa, cell-bound PA polypeptide (PA63). Complexes of PA63 and LF are internalized into acidic compartments where oligomerization of PA63 and entry of the enzymatic activity into the cytosol occur. DT binds the heparinbinding epidermal growth factor-like growth factor precursor (17) on the surface of cells and is cleaved and endocytosed. It translocates from endosomes to the cytosol similarly to PA. In contrast to the trafficking of PA and DT, PE binds to the ␣ 2 -macroglobulin receptor/low-density lipoprotein receptorrelated protein (LRP) (7) and undergoes endocytosis and retrograde transport through the Golgi apparatus and endoplasmic reticulum. During this process, most likely in the Golgi apparatus, PE becomes cleaved, enabling its translocation to the cytosol.
PA, PE, and DT have a recognition site for furin endoprotease (RXXR) at the position at which they are cleaved during activation (9) . Furin is a subtilisin-like, Ca 2ϩ -dependent, processing endoprotease (2) expressed at low levels by many eukaryotic cell types. Furin functions within the constitutive secretory pathway, where it performs a housekeeping function, cleaving receptor precursors and other proproteins. A similar protease, PACE4, whose abundance and substrate specificity resemble those of furin, has only recently been described. Genes encoding several types of PACE4, including PACE4A (11), -B (11), -C (24), and -D (24) , have been discovered. Although furin and PACE4 have similar sequences in the catalytic domains, their amino acid sequences diverge at the C terminus (22) . Both proteases have cysteine-rich regions, but furin has a transmembrane region which anchors it to the Golgi apparatus and plasma membranes (3, 21, 22) . Furin may become cleaved adjacent to the transmembrane domain to produce an extracellular, soluble, enzymatically active form. PACE4 lacks an anchoring sequence and is reported to be found only intracellularly (19) . Rehemtulla et al. (19) , using native and cleavage site mutants of von Willebrand factor as substrates for furin and PACE4, have shown that furin will cleave after the sequence RXXR, whereas the optimal sequence for furin recognition is RX(K/R)R. Their data also indicated that substrates containing a basic residue at the Ϫ2 position were cleaved more efficiently by PACE4, suggesting that PACE4 may have a more stringent requirement than furin for a basic residue at this Ϫ2 position.
In this study, we exploited the requirement for proteolytic activation of several wild-type and mutant toxins to assess the effect of cleavage site sequence variation on the sensitivity of cells that express either furin or PACE4. Our findings contrast with earlier work describing PACE4 distribution and recognition sequence (19) . We present evidence for the presence of PACE4 on the cell surface and show that like furin, PACE4 can activate anthrax toxin PA at the sequence RXXR.
MATERIALS AND METHODS
Materials. PE and DT were purchased from List Biological Laboratories. Bacillus anthracis PA was purified as described previously (14 Purification of native and mutated PA proteins. Transformed B. anthracis BH441 (23) expressing mutated PA proteins was grown at 37°C in 6-liter quantities in FA medium (23) containing 20 g of neomycin per ml in a BioFlo IV fermentor (New Brunswick Scientific Co., Inc., Edison, N.J.). PA was purified by MonoQ column chromatography (Pharmacia LKB Biotechnology, Piscataway, N.J.), using a gradient of 0 to 1 M NaCl in 10 mM bis-Tris propane-15 mM aminoethanol (pH 9.0) as described previously (8) . Purified mutant PA proteins are designated according to the sequence at positions 164 to 167.
Preparation of FP50. FP50, a fusion protein linking amino acids 1 to 254 from anthrax toxin lethal factor with domains Ib and III from PE (amino acid residues 362 to 608) and possessing an altered C-terminal sequence, LDER, was prepared as described previously (1, 8) .
Cell culture. Chinese hamster ovary-K1 (CHO) and furin-deficient CHO (FD11) cells were maintained in alpha minimal essential medium supplemented with 5% Fetal Clone II (HyClone, Logan, Utah) and 50 g of gentamicin per ml. Medium for FD11 cells transfected with the gene for furin (FD11/furin cells) or PACE4 (FD11/PACE4 cells) contained 400 g of G418 per ml. All cells were cultured in an atmosphere of 5% CO 2 at 37°C.
Transfection of FD11 cells with plasmids containing furin or PACE4 genes. Furin-deficient CHO cell line FD11 (8) was cotransfected with plasmid pED4NEO (20) , which contained the neo gene, and a plasmid containing either the human furin gene (20) or the gene encoding PACE4 (19) , using Lipofectamine (Life Technologies, Grand Island, N.Y.) according to the manufacturer's instructions. Transfectants were initially selected in medium containing 400 g of G418 per ml. Isolated, G418-resistant clones were selected by using cloning rings (Bellco Glass Inc., Vineland, N.J.) and expanded. These clones were screened for sensitivity to various toxins in cytotoxicity assays to identify cells that expressed furin or PACE4.
RT-PCR. Expression of the expected gene in the transfected cell lines was confirmed by using reverse transcriptase-coupled PCR (RT-PCR). RNA was extracted from 5 million cells of each cell line, using the Trizol reagent as recommended by the manufacturer (Gibco, Grand Island, N.Y.). Two micrograms of RNA was used to prepare cDNA which was then used as a template for PCR as recommended by the manufacturer (Perkin-Elmer, Norwalk, Conn.). Primers specific for the human furin or PACE4 cDNA sequence were used to identify the presence of the respective mRNA.
Cytotoxicity assays. The functional activities of PA proteins were assayed in combination with FP50 (50 ng/ml) on CHO, FD11, or transfected FD11 cells. Cells at 10 5 /ml were distributed on 96-well plates (Becton Dickinson and Co., Lincoln Park, N.J.) 1 day prior to assay. After the addition of PA proteins and FP50, the cells were incubated for 30 h at 37°C. Cell viability was determined by using MTT (0.5 mg/ml) as described previously (18) . The absorbance of the MTT product was measured at 540 nm in a microplate reader (Molecular Devices, Palo Alto, Calif.) and expressed as percentage of absorbance in the absence of toxin. All data shown are representative of three or more assays.
In vitro cleavage of wild-type and mutated toxins with purified, recombinant PACE4. Purified, recombinant PACE4 was a generous gift from R. LeDuc (Université de Sherbrooke, Québec, Québec, Canada). Wild-type or cleavagesite mutants of PA (1 g) were digested with 1 U of PACE4 (defined as the amount of enzyme that yields 1 pmol of AMC/min from the fluorogenic substrate boc-RVRR-AMC) for 2 h at 30°C in a buffer containing 100 mM HEPES (pH 7.6), 1 mM CaCl 2 , and 0.5% (vol/vol) Triton X-100. Digestion products were separated on sodium dodecyl sulfate (SDS)-10% polyacrylamide gels, transferred to nitrocellulose, and visualized by using a polyclonal antiserum against PA.
Iodination of PA and PA cleavage site mutants. PA, PA RAAR, and PA STRR were dialyzed in the Pierce Slide-a-lyzer 10K dialysis cassette system with 10 mM HEPES (pH 8.0) at 4°C. The dialyzed proteins were concentrated in Centricon 30 units (Amicon, Inc., Beverly, Mass.). The proteins were iodinated by using Bolton-Hunter reagent (Amersham, Arlington Heights, Ill.). The specific activities for PA and PA RAAR were 8 ϫ 10 5 cpm/g, and the specific activity obtained for PA STRR was 1. min at 15,000 rpm, and the protein concentrations of the supernatants were measured by using a bicinchoninic acid protein assay kit (Pierce, Rockford, Ill.). These supernatants were used as a source of protease to cleave iodinated toxin substrates.
In digestion assays, 0.1 g of PA or PA RAAR was incubated with extracts containing 0.02 g of cell proteins for 3 h at 37°C. The digestion products were separated on SDS-10% polyacrylamide gels. The gels were dried and exposed to film (Kodak XAR5) for 8 h.
Cleavage of iodinated toxins by intact cells. CHO, FD11, FD11/furin, and FD11/PACE4 cells were diluted to 5 ϫ 10 5 cells/ml and plated in 24-well Primaria plates (Falcon). Adherent cells were washed four times with buffer containing 10 mM HEPES (pH 7.2), 125 mM NaCl, 1 mM MgCl 2 , and 1 mM CaCl 2 at 4°C. One microgram of iodinated PA protein was added to wells containing 200 l of binding buffer (25 mM HEPES [pH 7.2], 100 mM NaCl, 2 mM CaCl 2 , 5 mM MgCl 2 , 1 mM EGTA, 1 mM EDTA, bovine serum albumin, [200 g/ml], gentamicin [50 g/ml]). The plates were incubated at 4°C for 18 h or 37°C for 3 h and then washed four times with binding buffer. The cells were lysed with 100 l of 0.2% SDS containing 1% Triton X-100, 10 l of DNase I (10 g/ml), and 10 l of 10% SDS as described previously (13) . The lysates were transferred to microcentrifuge tubes, the proteins were separated by SDS-polyacrylamide gel electrophoresis using precast 10% gels (Novex), and the gels were subjected to autoradiography.
RESULTS
Transfection of furin-deficient CHO cells with furin or PACE4 cDNAs. FD11, a furin-deficient CHO cell line, is resistant to a number of bacterial protein toxins that require proteolytic activation (8) . To date, no PACE4 mRNA has been identified in CHO cells (18a) . To investigate the toxin-processing capabilities of cells that express either furin or PACE4, FD11 cells were cotransfected with a plasmids containing the gene encoding furin or PACE4 together with a plasmid containing the neo gene. After selection with G418, the transfected cells were cloned and screened for their sensitivities to various toxins. Cells transfected with the furin gene were identified by assaying for sensitivity to both PE and PA RAAR in combination with FP50, a fusion protein consisting of the N terminus of LF genetically fused with the ADP-ribosylating domain of PE (1, 8) . It was used in place of LF, which is cytotoxic only for macrophages. Cells transfected with the gene for PACE4 were resistant to PE, but on screening with PA RAAR and FP50, several clones proved sensitive. One PA RAAR-sensitive clone was selected for extensive study.
To confirm that the selected clones contained and expressed the transfected gene, RNA isolated from furin-or PACE4-transfected FD11 cells was used as a template in RT-PCR to identify gene-specific sequences (Fig. 1 3) transcripts, and consequently no DNA could be amplified from the template by using specific primers. A 1.2-kb band was amplified from RNA prepared from FD11/furin cells (lane 2) and from FD11/PACE4 cells (lane 4). The sequences of the cDNAs from these bands correspond to the furin and PACE4 genes, respectively (data not shown). A second band of approximately 0.9 kb of unknown identity appears with the PACE4 cDNA (lane 4).
In general, transfection of FD11/furin cells restored to FD11 cells the pattern of toxin sensitivity seen with wild-type CHO cells ( Fig. 2 and Table 1 ). However, there were a few differences: the transfected cells were 10-fold less sensitive to PE, 3-fold less sensitive to PA, and 2-fold more sensitive to PA cleavage site mutant PA STRR than were wild-type CHO cells (Table 1) .
FD11/PACE4 cells were clearly distinguishable from FD11/ furin cells in terms of toxin sensitivity (and, by implication, substrate specificity of the proteases). Most strikingly, FD11/ PACE4 cells were completely resistant to PE (Fig. 3A and Table 1 ), which is believed to be activated in endosomes or in the trans-Golgi. FD11/PACE4 cells were more than 16-fold and more than 50-fold less sensitive to PA mutants FTKR and STRR, respectively, and 6-fold less sensitive to DT. In contrast, the FD11/PACE4 cells showed 10-fold increased sensitivity to PA (Fig. 3 and Table 1 ). Thus, transfection with PACE4 reversed the resistance of FD11 cells to only wild-type PA, PA RAAR, and to a much lesser extent PA FTKR.
Cleavage of PA proteins by purified PACE4. That PACE4-transfected cells were sensitive to PA RAAR and partially sensitive to PA FTKR ran counter to the initial hypothesis that PACE4 recognition required Ϫ1, Ϫ2, and Ϫ4 basic residues. To determine whether these proteins are substrates for PACE4 in vitro, we carried out digestions with purified enzyme and visualized the proteins on Western blots (Fig. 4) . The results were similar to the data obtained from the cytotoxicity assays (Fig. 3B) . Wild-type PA (lane 1) and PA RAAR (lane 3) were efficiently cleaved in a 2-h digest, and the PA63 digestion products from cleavage of PA FTKR (lane 5) and PA STRR (lane 7) are just visible. PE and DT were resistant to PACE4 cleavage (data not shown).
Cleavage of iodinated PA proteins by cell extracts. Furin is localized primarily to the trans-Golgi but is also found on the plasma membrane as well as in endosomes (16), whereas PACE4 was reported to be intracellular (19) . To determine whether whole-cell extracts could serve as a source of proteolytic activity to cleave PA and PA RAAR, we prepared extracts from wild-type CHO cells, FD11 cells, FD11/furin cells, and FD11/PACE4 cells. Approximately 50 ng of iodinated PA or PA RAAR was incubated with 20 ng of cell extracts for 3 h at 37°C. The digestion products are shown on autoradiographs of SDS-gels (Fig. 5) . As predicted, extracts that contained furin activity (lane 1 and 3) or PACE4 (lane 4) cleaved PA to the 63-kDa activated species although PACE4 cleavage was minimal. The majority of this cleavage was most likely performed by furin or PACE4 because (i) the extracts were prepared in buffers that maintain furin and are predicted to maintain PACE4 activities while inhibiting some other proteases and (ii) wild-type CHO cells do not express PACE4 (18a). FD11 cell extracts cleaved PA much less efficiently than did CHO cell extracts (lane 2), and FD11 cell extracts did not cleave PA RAAR (lane 7). Cleavage of native PA by FD11 cell extracts reflects the activity of proteases other than furin whose activities were not inhibited during preparation of the extracts (because native PA contains a tetrabasic site, it is a potential substrate for proteases in addition to furin). Cleavage of PA RAAR was detectable only in the presence of excess furin (lane 8). Extracts from FD11/PACE4 cells cleaved PA minimally and PA RAAR not at all (lanes 4 and 9, respectively). This observation correlates well with cleavage with purified PACE4 and results from cytotoxicity assays which indicate that PACE4 cleaves PA more efficiently than PA RAAR. These data further suggest that unlike furin, which is bound to cells via a transmembrane domain, the majority of PACE4 activity either is not tightly associated with cells or was lost or inactivated during preparation of the extracts.
Cleavage of iodinated PA proteins on the cell surface. To determine whether cleavage takes place on the cell surface, iodinated PA, PA RAAR, and PA STRR were incubated with cells at 4°C (Fig. 6A) . PA and PA RAAR were cleaved both by wild-type CHO (lanes 1 and 2, respectively) and by FD11 cell surface protease (lanes 4 and 5, respectively). Although the amount of furin at the cell surface cannot easily be quantitated, it appears that FD11/furin cells are significantly more efficient at processing PA and PA RAAR (Fig. 6A, lanes 7 and 8,  respectively) than are FD11 or FD11/PACE4 cells (Fig. 6A,  lanes 10 and 11, respectively) . Cleavage of PA STRR is not visible at 4°C and, although equal amounts of PA STRR was added to all assays, less PA STRR was recovered. PA STRR may bind less tightly to the surface of the mutated or transfected cells, or it may become unstable when bound to the surface of those cells.
When identical reactions were carried out at 37°C (Fig. 6B ), all substrates bound and were cleaved more efficiently. Interestingly, PA RAAR is cleaved well by FD11 cells, though the cells are completely resistant to the toxin. Cleavage of PA STRR is detected both in FD11/furin cells (Fig. 6B, lane 9) and in FD11/PACE4 cells (lane 12), suggesting either that cleavage occurs following endocytosis at 37°C or that the activating proteases are more active at physiologic temperatures.
DISCUSSION
Eukaryotic cells produce many growth factors, hormones, and enzymes in an inactive pro form. Upon transit through the regulated or constitutive secretory pathway, these proproteins become cleaved to their active, functional forms. A number of bacterial protein toxins have evolved to take advantage of the presence of activating proteases and are synthesized and secreted by their respective bacteria as protoxins. Through interaction with mammalian cells that possess appropriate proteases, the toxins become activated, an event which results in cell death. Toxins that may be activated by eukaryotic proteases include anthrax toxin PA, PE, and DT. Each of these toxins has been demonstrated to be activated at a specific amino acid sequence by the eukaryotic protease furin (5, 9, 10, 12, 13, 25) .
Expression from both furin and PACE4 genes has been detected in a number of different cell types (26) . Our goal was to determine whether the related proteases, furin and PACE4, have different sequence requirements for activating bacterial toxins. Both furin and PACE4 are present in cells in such low concentrations that it has thus far been possible to localize the enzymatic activities only to specific tissues unless expression of the proteases is elevated by transfection of the protease genes. Toxins provide the ideal tools for defining the specificities of these proteases, both because they are so sensitive to cleavage and because they are so potent when activated. We have previously found that cells that lack both furin and PACE4 cannot activate a PA cleavage site mutant, PA RAAR, and PE and are reduced in their ability to activate PA and DT (8) . Moehring et al. (15) demonstrated that the expression of furin in a furindeficient CHO cell line led to regained sensitivity to PE. Here, we have demonstrated that when the furin gene is expressed in FD11 cells, the cells regain sensitivity to both PA RAAR and PE. Results from transfection studies and in vitro digestions indicate that PACE4 can activate PA, PA RAAR, and to a much lesser extent PA FTKR but not PE or DT.
FD11 and FD11/furin cells are each less sensitive to wildtype PA plus FP50 than either CHO or FD11/PACE4 cells (Table 1 ). This observation is surprising in view of the data on toxin cleavage. In vitro cleavage using the cell extracts (Fig. 5 ) and cell surface cleavage of iodinated PA (Fig. 6A) show that native PA is cleaved very efficiently by the transfected cells. Although we have failed to demonstrate that furin can cleave PA at dibasic sequences (9), others, using alternative substrates, have shown that furin can recognize dibasic sequences (4, 6) . Thus, FD11/furin cells may have decreased sensitivity to PA because PA contains numerous dibasic sites that can become cleaved in the presence of excess furin, long incubation times, and other proteases present on the cell surface, resulting in partial degradation of the toxin. PA is activated by PACE4 on the cell surface (Table 1 and Fig. 6A ) but might not be degraded by PACE4 because PACE4 lacks a transmembrane domain and would not be concentrated on the cell surface.
The insensitivity of FD11/PACE4 cells to PE allows us to speculate about the specificity and intracellular localization of PACE4. Although both PE (cleavage sequence, RQPR) and the PA RAAR mutant contain the RXXR motif, only the latter toxin is activated by PACE4-containing cells. Inocencio et al. (10) demonstrated that in order to be cleaved by furin, PE required a pH of 5.4. The same may be true for PACE4. As stated above, PE and furin probably colocalize in endocytic vesicles or in the Golgi apparatus. An intracellular location for PACE4 has yet to be identified. It is therefore possible that PE and PACE4 are found in separate compartments and consequently do not interact. Alternatively, the protein structure of PE may obscure the cleavage site to PACE4.
We had expected that DT would be highly toxic to PACE4-containing cells because the DT cleavage site contains arginine residues at the Ϫ1, Ϫ2, and Ϫ4 positions and because like PA, DT is activated on the cell surface. However, FD11 cells and FD11/PACE4 cells are equally sensitive to DT. In contrast, FD11/furin cells are statistically significantly more sensitive to DT than are FD11 cells. Additionally, in vitro digestions of DT with purified PACE4 did not result in cleavage (data not shown). These observations suggest that DT is not activated by PACE4. However, as may be the case for PE, lack of cleavage could be explained if structural features of the toxin obscured the cleavage site from the protease.
Despite the fact that PACE4 does not activate DT, the data presented here are entirely consistent with PACE4 being secreted extracellularly. The lack of a transmembrane domain or sequence that would allow the protease to remain associated with the plasma membrane may result in soluble PACE4 being present in the culture supernatant. Soluble PACE4 would, therefore, not be present in washed cell extracts, which would explain the minimal cleavage of PA and complete lack of cleavage of PA RAAR by extracts of FD11/PACE4 cells (Fig.  5) . In intact FD11/PACE4 cells, cleavage of PA and PA RAAR of the cell surface is evident (Fig. 6A ) but does not exceed cleavage by FD11 cells. These results are consistent with PACE4 being released from cells but not remaining associated with the cell surface.
The cleavage of PA RAAR by purified PACE4 and FD11/ PACE4 cells contradicts the reported specificity of PACE4 for a basic residue at the Ϫ2 position in studies using von Willebrand factor as a substrate (19) . Like those authors, we have found clear differences in the substrate specificities of the two enzymes. FD11/furin cells were sensitive to mutated toxins containing dibasic cleavage sequences (Fig. 2B) , whereas FD11/PACE4 cells were much less or not sensitive to those toxins (Fig. 3B) . However, the two cell lines were equally sensitive to PA RAAR, indicating that, at least in assays using the anthrax toxin substrates, a Ϫ2 basic residue is not required for substrate recognition by PACE4.
Creemers et al. (6) found that a mutant of von Willebrand factor containing the sequence ASKR at the cleavage site was processed by recombinant furin but not by PACE4. In those experiments, the protease and the substrate were cotransfected into cells and the cleavage products were detected by radiolabeling. Our cytotoxicity data (Fig. 3B ), but not our in vitro cleavage data (Fig. 4) , are in agreement with their results. The discrepancies in these findings may indicate that the environment provided on the cell surface or in the cytosol may cause conformational changes in the substrates which results in the requirement of the Ϫ4 arginine for PACE4 recognition. Additionally, mutations in the cleavage site of PA or von Willebrand factor could affect folding of the protein with the effect of preventing access of the protease to the cleavage site. In conclusion, the data obtained from transfection and cytotoxicity experiments are similar.
We have provided evidence that proteins containing arginine residues at only the Ϫ1 and Ϫ4 positions may be substrates for PACE4 and that dibasic sequences may be substrates for PACE4. Our data are consistent with PACE4 being secreted from mammalian cells. Finally, we have demonstrated that PACE4 can play a role in the proteolytic activation of anthrax toxin on the surface of target cells.
